# AlloSource – FDA Inspection, Jul 9, 2019

Source: https://www.keypedia.com/records/fda_inspections/allosource/a73c94c3-bc1c-4020-83fd-1d48a4f68445
Source feed: FDA_Inspections

> FDA inspection 1097873 of AlloSource, July 09, 2019. Classification: No Action Indicated (NAI). 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1097873
- Company Name: AlloSource
- Inspection Date: 2019-07-09
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1263913 - 2025-03-04
- FDA Inspection 913479 - 2015-02-10

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/darla-j-christopher/64d3f47f-f3c0-4cfd-a3e8-4dc0e69d04bd)

Company: https://www.keypedia.com/companies/allosource/0bc5f979-d77b-4eab-b92e-b5079d4f9734

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d